Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer
Ontology highlight
ABSTRACT: Our findings demonstrate that CDCP1 is a novel modulator of HER2 signalling, and a biomarker for the stratification of breast cancer patients with poor prognosis GEP analysis of human breast cancer cell lines SKBR3 overexpressing CDCP1 and control.
ORGANISM(S): Homo sapiens
SUBMITTER: Francesco Bertoni
PROVIDER: E-GEOD-67019 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA